Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy - cnbc.com
The story
- Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy cnbc.com
- Novo Nordisk Slims Down Name to Novo WSJ
- No more Nordisk as Novo goes it alone amid rebranding push fiercepharma.com
- Novo Will Use Shorter Name to Boost Recognition in Obesity bloomberg.com
- Novo Nordisk rebrands as 'Novo', announces cultural reset Reuters
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events